 Shriram Jakate
Concepts (435)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colonic Polyps | 7 | 2022 | 36 | 2.010 |
Why?
| | Adenoma | 6 | 2022 | 63 | 1.930 |
Why?
| | Colonoscopy | 15 | 2022 | 88 | 1.790 |
Why?
| | Colorectal Neoplasms | 7 | 2022 | 125 | 1.760 |
Why?
| | Biopsy | 18 | 2021 | 283 | 1.640 |
Why?
| | Liver Neoplasms | 7 | 2018 | 117 | 1.300 |
Why?
| | Liver | 14 | 2021 | 214 | 1.270 |
Why?
| | Esophagus | 4 | 2015 | 60 | 1.100 |
Why?
| | Barrett Esophagus | 3 | 2014 | 19 | 1.080 |
Why?
| | Colon | 8 | 2018 | 155 | 1.020 |
Why?
| | Early Detection of Cancer | 5 | 2018 | 91 | 0.980 |
Why?
| | Stomach Neoplasms | 4 | 2011 | 40 | 0.950 |
Why?
| | Neoplasms, Second Primary | 4 | 2022 | 42 | 0.930 |
Why?
| | Adenocarcinoma | 5 | 2015 | 237 | 0.920 |
Why?
| | Esophagoscopy | 3 | 2015 | 18 | 0.840 |
Why?
| | Middle Aged | 44 | 2021 | 11209 | 0.820 |
Why?
| | Humans | 75 | 2022 | 31481 | 0.780 |
Why?
| | Carcinoma, Hepatocellular | 4 | 2018 | 41 | 0.780 |
Why?
| | Esophagitis | 3 | 2015 | 11 | 0.760 |
Why?
| | Female | 54 | 2021 | 18253 | 0.760 |
Why?
| | Male | 57 | 2020 | 17583 | 0.750 |
Why?
| | Population Surveillance | 4 | 2018 | 127 | 0.720 |
Why?
| | Gastrointestinal Hemorrhage | 5 | 2009 | 29 | 0.700 |
Why?
| | Diagnostic Errors | 3 | 2014 | 48 | 0.700 |
Why?
| | Intestinal Mucosa | 11 | 2009 | 235 | 0.700 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2015 | 46 | 0.670 |
Why?
| | Lymphoid Tissue | 2 | 2016 | 22 | 0.670 |
Why?
| | Hirschsprung Disease | 1 | 2016 | 9 | 0.670 |
Why?
| | Aged | 31 | 2018 | 10295 | 0.640 |
Why?
| | Adenomyoma | 1 | 2015 | 1 | 0.630 |
Why?
| | Unnecessary Procedures | 1 | 2016 | 30 | 0.630 |
Why?
| | Enterocolitis | 2 | 2006 | 5 | 0.630 |
Why?
| | Gallbladder Neoplasms | 1 | 2015 | 6 | 0.630 |
Why?
| | Intestines | 3 | 2014 | 114 | 0.630 |
Why?
| | Liver Cirrhosis | 4 | 2010 | 60 | 0.600 |
Why?
| | Carcinoma | 1 | 2016 | 84 | 0.590 |
Why?
| | Radiotherapy | 2 | 2015 | 65 | 0.590 |
Why?
| | Radiation Injuries | 2 | 2015 | 44 | 0.590 |
Why?
| | Quality of Health Care | 1 | 2016 | 141 | 0.570 |
Why?
| | Gastrointestinal Stromal Tumors | 2 | 2011 | 30 | 0.520 |
Why?
| | Adult | 35 | 2018 | 9779 | 0.510 |
Why?
| | Liver Diseases | 2 | 2013 | 40 | 0.510 |
Why?
| | Ileum | 3 | 2011 | 31 | 0.510 |
Why?
| | Colonic Neoplasms | 6 | 2010 | 84 | 0.500 |
Why?
| | Immunohistochemistry | 12 | 2015 | 494 | 0.500 |
Why?
| | Stomach | 3 | 2014 | 19 | 0.480 |
Why?
| | Anus Neoplasms | 3 | 2020 | 9 | 0.470 |
Why?
| | Giardia | 1 | 2011 | 1 | 0.470 |
Why?
| | Giardiasis | 1 | 2011 | 1 | 0.470 |
Why?
| | Liver Transplantation | 3 | 2009 | 114 | 0.460 |
Why?
| | Leiomyoma | 1 | 2011 | 11 | 0.460 |
Why?
| | Biopsy, Fine-Needle | 5 | 2018 | 54 | 0.440 |
Why?
| | Esophageal Neoplasms | 3 | 2014 | 61 | 0.420 |
Why?
| | Mast Cells | 3 | 2007 | 45 | 0.410 |
Why?
| | Retrospective Studies | 12 | 2020 | 3591 | 0.410 |
Why?
| | Duodenal Diseases | 2 | 2008 | 8 | 0.410 |
Why?
| | Surgical Instruments | 1 | 2009 | 30 | 0.400 |
Why?
| | Liver Failure | 1 | 2009 | 14 | 0.390 |
Why?
| | Intussusception | 1 | 2009 | 4 | 0.390 |
Why?
| | Appendix | 1 | 2009 | 3 | 0.390 |
Why?
| | Cystic Fibrosis | 1 | 2009 | 15 | 0.390 |
Why?
| | Appendicitis | 1 | 2009 | 14 | 0.390 |
Why?
| | Carcinoid Tumor | 1 | 2008 | 21 | 0.370 |
Why?
| | Plasmacytoma | 1 | 2008 | 19 | 0.370 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2022 | 30 | 0.370 |
Why?
| | Hepatitis | 2 | 2006 | 9 | 0.370 |
Why?
| | Iron Compounds | 1 | 2008 | 2 | 0.360 |
Why?
| | Melanosis | 1 | 2008 | 4 | 0.360 |
Why?
| | Iron | 1 | 2008 | 19 | 0.360 |
Why?
| | Diarrhea | 3 | 2009 | 50 | 0.360 |
Why?
| | Diagnosis, Differential | 8 | 2015 | 467 | 0.350 |
Why?
| | Gastric Mucosa | 2 | 2006 | 13 | 0.330 |
Why?
| | Mastocytosis, Systemic | 1 | 2006 | 4 | 0.320 |
Why?
| | Mesenchymoma | 1 | 2006 | 2 | 0.320 |
Why?
| | Colitis, Ulcerative | 3 | 2010 | 74 | 0.320 |
Why?
| | Arteriovenous Malformations | 1 | 2006 | 3 | 0.320 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2006 | 9 | 0.320 |
Why?
| | Histocytochemistry | 3 | 2011 | 34 | 0.310 |
Why?
| | Arteries | 1 | 2006 | 24 | 0.310 |
Why?
| | Adrenal Glands | 1 | 2005 | 11 | 0.310 |
Why?
| | Aged, 80 and over | 12 | 2015 | 5234 | 0.310 |
Why?
| | Candidiasis | 1 | 2005 | 23 | 0.300 |
Why?
| | Celiac Disease | 1 | 2005 | 10 | 0.300 |
Why?
| | Immunocompromised Host | 1 | 2005 | 55 | 0.300 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 2005 | 7 | 0.300 |
Why?
| | Neoplasms, Multiple Primary | 3 | 2018 | 40 | 0.290 |
Why?
| | Fatty Liver, Alcoholic | 2 | 2019 | 12 | 0.290 |
Why?
| | Granular Cell Tumor | 2 | 2007 | 5 | 0.290 |
Why?
| | Lymph Nodes | 1 | 2005 | 84 | 0.280 |
Why?
| | Hepatomegaly | 2 | 2018 | 6 | 0.270 |
Why?
| | Autoantibodies | 1 | 2004 | 119 | 0.270 |
Why?
| | Cerebral Hemorrhage | 1 | 2005 | 141 | 0.260 |
Why?
| | Rectum | 4 | 2016 | 72 | 0.260 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2012 | 84 | 0.260 |
Why?
| | Sarcoma | 1 | 2006 | 139 | 0.260 |
Why?
| | Pancreatic Pseudocyst | 1 | 2002 | 1 | 0.250 |
Why?
| | Glomus Tumor | 1 | 2002 | 2 | 0.250 |
Why?
| | Rectal Neoplasms | 2 | 2013 | 28 | 0.250 |
Why?
| | Hepatectomy | 2 | 2018 | 65 | 0.250 |
Why?
| | Liver Diseases, Alcoholic | 3 | 2009 | 45 | 0.240 |
Why?
| | Hepatitis, Autoimmune | 2 | 2017 | 9 | 0.230 |
Why?
| | Fatal Outcome | 3 | 2006 | 75 | 0.230 |
Why?
| | Oxidative Stress | 4 | 2009 | 140 | 0.220 |
Why?
| | Hyperplasia | 3 | 2018 | 26 | 0.220 |
Why?
| | Condylomata Acuminata | 1 | 2020 | 1 | 0.220 |
Why?
| | Microscopy | 2 | 2011 | 14 | 0.210 |
Why?
| | Papillomavirus Infections | 1 | 2020 | 38 | 0.210 |
Why?
| | Prognosis | 4 | 2015 | 1028 | 0.210 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 1999 | 1 | 0.200 |
Why?
| | Risk Factors | 5 | 2018 | 2664 | 0.200 |
Why?
| | Adolescent | 7 | 2015 | 2667 | 0.190 |
Why?
| | Lung Neoplasms | 1 | 2005 | 756 | 0.190 |
Why?
| | Pancreatic Neoplasms | 3 | 2006 | 181 | 0.180 |
Why?
| | Predictive Value of Tests | 5 | 2014 | 637 | 0.180 |
Why?
| | Portal Vein | 1 | 2018 | 47 | 0.180 |
Why?
| | Colon, Sigmoid | 2 | 2016 | 18 | 0.180 |
Why?
| | Neoplasm Invasiveness | 3 | 2012 | 104 | 0.180 |
Why?
| | Infant, Newborn | 2 | 2020 | 754 | 0.180 |
Why?
| | Aromatase Inhibitors | 1 | 2017 | 9 | 0.170 |
Why?
| | Nitriles | 1 | 2017 | 17 | 0.170 |
Why?
| | Triazoles | 1 | 2017 | 32 | 0.170 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 149 | 0.170 |
Why?
| | Colon, Descending | 1 | 2016 | 1 | 0.170 |
Why?
| | Ulcer | 2 | 2008 | 7 | 0.170 |
Why?
| | Neoplasm Metastasis | 2 | 2018 | 129 | 0.170 |
Why?
| | Prospective Studies | 3 | 2013 | 1934 | 0.160 |
Why?
| | Ethanol | 4 | 2019 | 138 | 0.160 |
Why?
| | Mass Screening | 2 | 2018 | 199 | 0.160 |
Why?
| | Metaplasia | 2 | 2014 | 11 | 0.160 |
Why?
| | Fatty Liver | 3 | 2019 | 40 | 0.160 |
Why?
| | Infant | 2 | 2016 | 642 | 0.160 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 264 | 0.160 |
Why?
| | Cholecystectomy | 1 | 2015 | 19 | 0.150 |
Why?
| | Academic Medical Centers | 2 | 2016 | 158 | 0.150 |
Why?
| | Eosinophilia | 2 | 2007 | 49 | 0.150 |
Why?
| | HIV Infections | 2 | 2020 | 951 | 0.140 |
Why?
| | Tomography, X-Ray Computed | 7 | 2013 | 891 | 0.140 |
Why?
| | Jejunal Diseases | 2 | 2005 | 5 | 0.140 |
Why?
| | Neoplasms, Complex and Mixed | 1 | 2014 | 1 | 0.140 |
Why?
| | Adenoma, Liver Cell | 1 | 2014 | 1 | 0.140 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2014 | 42 | 0.140 |
Why?
| | Neuroendocrine Tumors | 1 | 2015 | 48 | 0.140 |
Why?
| | Oncogene Proteins, Viral | 1 | 1993 | 7 | 0.140 |
Why?
| | Alcoholism | 2 | 2019 | 90 | 0.140 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2013 | 2 | 0.130 |
Why?
| | Carcinoma, Adenosquamous | 1 | 2013 | 4 | 0.130 |
Why?
| | Gastrointestinal Tract | 2 | 2011 | 52 | 0.130 |
Why?
| | Repressor Proteins | 1 | 1993 | 44 | 0.130 |
Why?
| | Needles | 1 | 2013 | 18 | 0.130 |
Why?
| | Animals | 11 | 2019 | 5312 | 0.130 |
Why?
| | Ultrasonography | 2 | 2018 | 210 | 0.130 |
Why?
| | Adenomatous Polyps | 1 | 2013 | 7 | 0.130 |
Why?
| | Proctocolitis | 1 | 2012 | 2 | 0.120 |
Why?
| | Lymphogranuloma Venereum | 1 | 2012 | 3 | 0.120 |
Why?
| | Precancerous Conditions | 1 | 2012 | 27 | 0.120 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1993 | 91 | 0.120 |
Why?
| | Chlamydia trachomatis | 1 | 2012 | 16 | 0.120 |
Why?
| | Adenocarcinoma, Mucinous | 1 | 2012 | 6 | 0.120 |
Why?
| | Breast Neoplasms | 1 | 2017 | 442 | 0.120 |
Why?
| | Anal Canal | 1 | 2012 | 14 | 0.120 |
Why?
| | Neoadjuvant Therapy | 1 | 2012 | 71 | 0.120 |
Why?
| | Chronic Disease | 4 | 2009 | 544 | 0.120 |
Why?
| | Endotoxemia | 2 | 2009 | 29 | 0.120 |
Why?
| | Mitotic Index | 1 | 2011 | 8 | 0.120 |
Why?
| | Nitric Oxide | 2 | 2009 | 107 | 0.120 |
Why?
| | Gastroscopy | 1 | 2011 | 10 | 0.120 |
Why?
| | Carcinoma, Squamous Cell | 1 | 1993 | 207 | 0.120 |
Why?
| | Treatment Outcome | 6 | 2018 | 3910 | 0.110 |
Why?
| | Oxidants | 1 | 2011 | 29 | 0.110 |
Why?
| | Particulate Matter | 1 | 2011 | 21 | 0.110 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 63 | 0.110 |
Why?
| | alpha-Fetoproteins | 1 | 2010 | 5 | 0.110 |
Why?
| | Ultrasonography, Interventional | 1 | 2011 | 73 | 0.110 |
Why?
| | Pancreas | 3 | 2006 | 36 | 0.110 |
Why?
| | Membrane Glycoproteins | 4 | 1992 | 111 | 0.110 |
Why?
| | Colectomy | 1 | 2010 | 33 | 0.110 |
Why?
| | Incidental Findings | 1 | 2010 | 20 | 0.110 |
Why?
| | alpha-Synuclein | 1 | 2012 | 147 | 0.100 |
Why?
| | Lymphoma, Large-Cell, Immunoblastic | 1 | 2010 | 1 | 0.100 |
Why?
| | Gastroesophageal Reflux | 2 | 2007 | 35 | 0.100 |
Why?
| | Illinois | 2 | 2015 | 266 | 0.100 |
Why?
| | Tomography | 1 | 2009 | 12 | 0.100 |
Why?
| | Radiography, Abdominal | 1 | 2009 | 7 | 0.100 |
Why?
| | Dextran Sulfate | 1 | 2009 | 5 | 0.100 |
Why?
| | Lymphatic Metastasis | 2 | 2005 | 107 | 0.100 |
Why?
| | Cell Count | 2 | 2007 | 115 | 0.100 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 2010 | 100 | 0.100 |
Why?
| | Lactobacillus rhamnosus | 1 | 2009 | 6 | 0.100 |
Why?
| | Mucins | 1 | 2009 | 5 | 0.100 |
Why?
| | Appendectomy | 1 | 2009 | 13 | 0.100 |
Why?
| | Colitis | 1 | 2009 | 34 | 0.100 |
Why?
| | Equipment Design | 1 | 2009 | 198 | 0.100 |
Why?
| | Probiotics | 1 | 2009 | 18 | 0.100 |
Why?
| | Cholangiocarcinoma | 1 | 2008 | 8 | 0.090 |
Why?
| | Bile Duct Neoplasms | 1 | 2008 | 10 | 0.090 |
Why?
| | Cysts | 1 | 2008 | 21 | 0.090 |
Why?
| | Neoplasm Staging | 3 | 2017 | 481 | 0.090 |
Why?
| | Duodenoscopy | 1 | 2008 | 2 | 0.090 |
Why?
| | Anus Diseases | 1 | 2008 | 8 | 0.090 |
Why?
| | Sleep Deprivation | 1 | 2009 | 74 | 0.090 |
Why?
| | Formaldehyde | 2 | 1998 | 14 | 0.090 |
Why?
| | Chemokines, CC | 1 | 2007 | 8 | 0.090 |
Why?
| | Radiography | 1 | 2010 | 717 | 0.090 |
Why?
| | Alanine Transaminase | 1 | 2007 | 24 | 0.090 |
Why?
| | Young Adult | 2 | 2013 | 2277 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 5 | 2009 | 494 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2007 | 23 | 0.090 |
Why?
| | Biopsy, Needle | 1 | 2008 | 117 | 0.090 |
Why?
| | Combined Modality Therapy | 3 | 2013 | 456 | 0.080 |
Why?
| | Graft vs Host Disease | 1 | 2007 | 55 | 0.080 |
Why?
| | Gastrointestinal Diseases | 1 | 2007 | 42 | 0.080 |
Why?
| | Homosexuality, Male | 2 | 2020 | 25 | 0.080 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2001 | 136 | 0.080 |
Why?
| | Simplexvirus | 1 | 2006 | 11 | 0.080 |
Why?
| | Endosonography | 1 | 2006 | 15 | 0.080 |
Why?
| | Sleep Apnea, Obstructive | 1 | 2007 | 72 | 0.080 |
Why?
| | Bone Marrow Transplantation | 1 | 2006 | 40 | 0.080 |
Why?
| | Liposarcoma | 1 | 2006 | 16 | 0.080 |
Why?
| | Liver Glycogen | 1 | 2006 | 1 | 0.080 |
Why?
| | Diabetes Mellitus | 1 | 2008 | 150 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2018 | 832 | 0.080 |
Why?
| | Ranitidine | 1 | 2006 | 4 | 0.080 |
Why?
| | Histamine H1 Antagonists, Non-Sedating | 1 | 2006 | 4 | 0.080 |
Why?
| | Cetirizine | 1 | 2006 | 7 | 0.080 |
Why?
| | Rats | 5 | 2009 | 966 | 0.080 |
Why?
| | Duodenum | 1 | 2006 | 13 | 0.080 |
Why?
| | Registries | 1 | 2008 | 214 | 0.080 |
Why?
| | Tryptases | 1 | 2006 | 10 | 0.080 |
Why?
| | Pancreatectomy | 2 | 2006 | 18 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2007 | 82 | 0.080 |
Why?
| | Serine Endopeptidases | 1 | 2006 | 19 | 0.080 |
Why?
| | Jugular Veins | 1 | 2005 | 6 | 0.080 |
Why?
| | Carcinosarcoma | 1 | 2005 | 4 | 0.080 |
Why?
| | Choristoma | 2 | 2003 | 9 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2005 | 26 | 0.080 |
Why?
| | Duodenitis | 1 | 2005 | 1 | 0.080 |
Why?
| | Ileitis | 1 | 2005 | 1 | 0.080 |
Why?
| | Enteritis | 1 | 2005 | 2 | 0.080 |
Why?
| | Kidney Failure, Chronic | 1 | 2008 | 176 | 0.080 |
Why?
| | Lymphoma, T-Cell | 1 | 2005 | 6 | 0.080 |
Why?
| | Intestinal Neoplasms | 1 | 2005 | 13 | 0.070 |
Why?
| | Drug Therapy, Combination | 1 | 2006 | 265 | 0.070 |
Why?
| | Pyloric Antrum | 1 | 2005 | 3 | 0.070 |
Why?
| | Gastritis | 1 | 2005 | 3 | 0.070 |
Why?
| | Hypertension | 1 | 2008 | 283 | 0.070 |
Why?
| | Helicobacter Infections | 1 | 2005 | 4 | 0.070 |
Why?
| | Helicobacter pylori | 1 | 2005 | 5 | 0.070 |
Why?
| | Kidney Transplantation | 1 | 2006 | 141 | 0.070 |
Why?
| | Organ Size | 2 | 2018 | 122 | 0.070 |
Why?
| | Mice | 3 | 2019 | 1894 | 0.070 |
Why?
| | Endoscopy, Digestive System | 1 | 2003 | 10 | 0.070 |
Why?
| | Anti-Inflammatory Agents | 2 | 2003 | 109 | 0.070 |
Why?
| | Intestinal Obstruction | 1 | 2003 | 14 | 0.060 |
Why?
| | Child | 3 | 2007 | 1572 | 0.060 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2006 | 224 | 0.060 |
Why?
| | Capillaries | 1 | 2002 | 15 | 0.060 |
Why?
| | Prevalence | 1 | 2004 | 544 | 0.060 |
Why?
| | Parkinson Disease | 1 | 2012 | 1180 | 0.060 |
Why?
| | Permeability | 3 | 2009 | 143 | 0.060 |
Why?
| | Vasculitis | 1 | 2002 | 35 | 0.060 |
Why?
| | Ganglioneuroma | 1 | 2002 | 6 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2007 | 1240 | 0.060 |
Why?
| | Neuroblastoma | 1 | 2002 | 24 | 0.060 |
Why?
| | Digestive System | 1 | 2001 | 19 | 0.060 |
Why?
| | Drug Resistance | 3 | 2007 | 68 | 0.060 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 178 | 0.060 |
Why?
| | Metalloproteins | 1 | 2001 | 1 | 0.060 |
Why?
| | Hepatitis, Chronic | 1 | 2001 | 2 | 0.060 |
Why?
| | Ribosomal Proteins | 1 | 2001 | 5 | 0.060 |
Why?
| | Diet | 2 | 2019 | 202 | 0.060 |
Why?
| | Anastomosis, Surgical | 2 | 2003 | 56 | 0.050 |
Why?
| | ABO Blood-Group System | 2 | 1990 | 7 | 0.050 |
Why?
| | Observer Variation | 1 | 2020 | 146 | 0.050 |
Why?
| | Interferon-alpha | 1 | 2001 | 71 | 0.050 |
Why?
| | Nuclear Proteins | 1 | 2001 | 97 | 0.050 |
Why?
| | S100 Proteins | 1 | 1999 | 6 | 0.050 |
Why?
| | Hepatitis C | 1 | 2001 | 68 | 0.050 |
Why?
| | Lysosomes | 1 | 1999 | 25 | 0.050 |
Why?
| | Metabolic Networks and Pathways | 1 | 2019 | 16 | 0.050 |
Why?
| | Binge Drinking | 1 | 2019 | 13 | 0.050 |
Why?
| | Triglycerides | 1 | 2019 | 50 | 0.050 |
Why?
| | Lipid Metabolism | 1 | 2019 | 50 | 0.050 |
Why?
| | Hepatic Veins | 1 | 2018 | 9 | 0.050 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2009 | 70 | 0.050 |
Why?
| | Ligation | 1 | 2018 | 37 | 0.050 |
Why?
| | Swine | 1 | 2018 | 117 | 0.050 |
Why?
| | Random Allocation | 1 | 2018 | 164 | 0.050 |
Why?
| | Hamartoma | 1 | 1998 | 1 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2014 | 174 | 0.050 |
Why?
| | Mitochondria | 2 | 2011 | 91 | 0.050 |
Why?
| | Mice, Knockout | 1 | 2019 | 399 | 0.040 |
Why?
| | Appendiceal Neoplasms | 1 | 1997 | 4 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2020 | 886 | 0.040 |
Why?
| | Neurofibromatosis 1 | 1 | 1997 | 4 | 0.040 |
Why?
| | Acute Disease | 2 | 2009 | 254 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2019 | 351 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 1996 | 68 | 0.040 |
Why?
| | Epithelial Cells | 2 | 2007 | 101 | 0.040 |
Why?
| | Intestinal Absorption | 2 | 2009 | 41 | 0.040 |
Why?
| | Body Weight | 2 | 2009 | 167 | 0.040 |
Why?
| | United States | 2 | 2018 | 2539 | 0.040 |
Why?
| | Hospitals, University | 1 | 2015 | 46 | 0.040 |
Why?
| | Incidence | 1 | 2018 | 829 | 0.040 |
Why?
| | Wound Healing | 1 | 1996 | 175 | 0.040 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2014 | 1 | 0.040 |
Why?
| | Glypicans | 1 | 2014 | 1 | 0.040 |
Why?
| | Serum Amyloid A Protein | 1 | 2014 | 2 | 0.040 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2014 | 5 | 0.040 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2014 | 13 | 0.030 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2014 | 9 | 0.030 |
Why?
| | Immunosuppressive Agents | 2 | 2007 | 163 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2014 | 26 | 0.030 |
Why?
| | Liver Function Tests | 2 | 2006 | 33 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2014 | 63 | 0.030 |
Why?
| | Papillomaviridae | 1 | 1993 | 30 | 0.030 |
Why?
| | Genetic Markers | 1 | 1993 | 51 | 0.030 |
Why?
| | Ureter | 2 | 1990 | 25 | 0.030 |
Why?
| | beta Catenin | 1 | 2014 | 46 | 0.030 |
Why?
| | Neoplasm, Residual | 1 | 2012 | 10 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2012 | 2028 | 0.030 |
Why?
| | Unsafe Sex | 1 | 2012 | 7 | 0.030 |
Why?
| | Bacteriological Techniques | 1 | 2012 | 20 | 0.030 |
Why?
| | Neurites | 1 | 2012 | 12 | 0.030 |
Why?
| | Antibodies, Monoclonal | 2 | 1992 | 301 | 0.030 |
Why?
| | Substance P | 1 | 2012 | 19 | 0.030 |
Why?
| | Coinfection | 1 | 2012 | 33 | 0.030 |
Why?
| | Prednisone | 2 | 2003 | 75 | 0.030 |
Why?
| | District of Columbia | 1 | 2011 | 4 | 0.030 |
Why?
| | Occludin | 1 | 2011 | 13 | 0.030 |
Why?
| | Zonula Occludens-1 Protein | 1 | 2011 | 18 | 0.030 |
Why?
| | Electric Impedance | 1 | 2011 | 28 | 0.030 |
Why?
| | Tight Junctions | 1 | 2011 | 29 | 0.030 |
Why?
| | Phosphoproteins | 1 | 2011 | 36 | 0.030 |
Why?
| | Air Pollution | 1 | 2011 | 15 | 0.030 |
Why?
| | Caco-2 Cells | 1 | 2011 | 53 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2012 | 390 | 0.030 |
Why?
| | Particle Size | 1 | 2011 | 71 | 0.030 |
Why?
| | Cell Death | 1 | 2011 | 68 | 0.030 |
Why?
| | Mutation | 1 | 1993 | 464 | 0.030 |
Why?
| | Antigen-Antibody Reactions | 1 | 1990 | 8 | 0.030 |
Why?
| | NF-kappa B | 1 | 2011 | 112 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2011 | 120 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 133 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2012 | 1273 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2010 | 156 | 0.030 |
Why?
| | Sigmoidoscopy | 1 | 2010 | 8 | 0.030 |
Why?
| | Inflammation | 2 | 2008 | 360 | 0.030 |
Why?
| | Abdomen | 1 | 2010 | 13 | 0.030 |
Why?
| | Abdominal Muscles | 1 | 2010 | 8 | 0.030 |
Why?
| | Practice Guidelines as Topic | 1 | 2013 | 389 | 0.030 |
Why?
| | Rectal Diseases | 1 | 2009 | 10 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2011 | 230 | 0.020 |
Why?
| | Peroxidase | 1 | 2009 | 18 | 0.020 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2010 | 151 | 0.020 |
Why?
| | Logistic Models | 1 | 2010 | 479 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2012 | 412 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 160 | 0.020 |
Why?
| | Administration, Rectal | 2 | 1998 | 6 | 0.020 |
Why?
| | Sexuality | 1 | 2008 | 21 | 0.020 |
Why?
| | Receptors, CCR3 | 1 | 2007 | 2 | 0.020 |
Why?
| | Interleukin-5 | 1 | 2007 | 10 | 0.020 |
Why?
| | Adipose Tissue | 1 | 2008 | 98 | 0.020 |
Why?
| | Transplantation Conditioning | 1 | 2007 | 40 | 0.020 |
Why?
| | Dogs | 2 | 1998 | 283 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 191 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2009 | 548 | 0.020 |
Why?
| | Splenectomy | 1 | 2006 | 8 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 405 | 0.020 |
Why?
| | Adrenal Cortex Hormones | 1 | 2007 | 100 | 0.020 |
Why?
| | Gastrectomy | 1 | 2006 | 26 | 0.020 |
Why?
| | Glycogen Storage Disease | 1 | 2006 | 2 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2007 | 116 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2007 | 371 | 0.020 |
Why?
| | Gene Expression | 1 | 2007 | 272 | 0.020 |
Why?
| | Transplantation, Homologous | 1 | 2007 | 292 | 0.020 |
Why?
| | Apoptosis | 1 | 2007 | 292 | 0.020 |
Why?
| | Cell Degranulation | 1 | 2005 | 8 | 0.020 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2005 | 11 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2010 | 1452 | 0.020 |
Why?
| | Cold Temperature | 1 | 2005 | 39 | 0.020 |
Why?
| | Reoperation | 1 | 2010 | 938 | 0.020 |
Why?
| | Japan | 1 | 2005 | 13 | 0.020 |
Why?
| | Korea | 1 | 2005 | 12 | 0.020 |
Why?
| | Hydrocortisone | 1 | 2005 | 54 | 0.020 |
Why?
| | Proteins | 1 | 2005 | 94 | 0.020 |
Why?
| | Child, Preschool | 1 | 2007 | 786 | 0.020 |
Why?
| | Sex Distribution | 1 | 2005 | 89 | 0.020 |
Why?
| | Atrophy | 1 | 2005 | 108 | 0.020 |
Why?
| | Heart Rate | 1 | 2005 | 161 | 0.020 |
Why?
| | Azathioprine | 1 | 2003 | 5 | 0.020 |
Why?
| | Budesonide | 1 | 2003 | 5 | 0.020 |
Why?
| | Histamine H2 Antagonists | 1 | 2003 | 8 | 0.020 |
Why?
| | Dilatation, Pathologic | 1 | 2003 | 9 | 0.020 |
Why?
| | Histamine H1 Antagonists | 1 | 2003 | 9 | 0.020 |
Why?
| | Proton Pump Inhibitors | 1 | 2003 | 15 | 0.020 |
Why?
| | Esophageal Perforation | 1 | 2003 | 10 | 0.020 |
Why?
| | Gastrointestinal Motility | 1 | 2003 | 19 | 0.020 |
Why?
| | Proton Pumps | 1 | 2003 | 16 | 0.020 |
Why?
| | Neutrophils | 1 | 2005 | 133 | 0.020 |
Why?
| | Blood Pressure | 1 | 2005 | 260 | 0.020 |
Why?
| | Deglutition Disorders | 1 | 2003 | 47 | 0.020 |
Why?
| | Catheterization | 1 | 2003 | 62 | 0.020 |
Why?
| | Eosinophils | 1 | 2003 | 47 | 0.020 |
Why?
| | Laparotomy | 1 | 2003 | 25 | 0.020 |
Why?
| | Time Factors | 2 | 2001 | 1902 | 0.020 |
Why?
| | Recurrence | 1 | 2003 | 389 | 0.020 |
Why?
| | Endotoxins | 1 | 2001 | 27 | 0.010 |
Why?
| | Nausea | 1 | 2001 | 25 | 0.010 |
Why?
| | Species Specificity | 1 | 2001 | 78 | 0.010 |
Why?
| | Hepatocytes | 1 | 2001 | 13 | 0.010 |
Why?
| | RNA-Binding Proteins | 1 | 2001 | 26 | 0.010 |
Why?
| | Antibodies | 1 | 2001 | 72 | 0.010 |
Why?
| | Liver Regeneration | 1 | 2001 | 27 | 0.010 |
Why?
| | Epithelium | 2 | 1990 | 31 | 0.010 |
Why?
| | Genetic Variation | 1 | 2001 | 113 | 0.010 |
Why?
| | RNA, Viral | 1 | 2001 | 163 | 0.010 |
Why?
| | Fatigue | 1 | 2001 | 67 | 0.010 |
Why?
| | Hepacivirus | 1 | 2001 | 74 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2001 | 295 | 0.010 |
Why?
| | Proctitis | 1 | 1998 | 3 | 0.010 |
Why?
| | Compliance | 1 | 1998 | 8 | 0.010 |
Why?
| | Manometry | 1 | 1998 | 28 | 0.010 |
Why?
| | Collagen | 1 | 1998 | 111 | 0.010 |
Why?
| | Disease Progression | 1 | 2001 | 861 | 0.010 |
Why?
| | von Willebrand Factor | 1 | 1996 | 11 | 0.010 |
Why?
| | Microcirculation | 1 | 1996 | 40 | 0.010 |
Why?
| | Hydroxyproline | 1 | 1996 | 7 | 0.010 |
Why?
| | Tensile Strength | 1 | 1996 | 31 | 0.010 |
Why?
| | Pilot Projects | 1 | 1997 | 455 | 0.010 |
Why?
| | Intraoperative Care | 1 | 1996 | 58 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1996 | 227 | 0.010 |
Why?
| | Laparoscopy | 1 | 1997 | 190 | 0.010 |
Why?
| | Survival Rate | 1 | 1996 | 465 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1990 | 155 | 0.010 |
Why?
| | Analysis of Variance | 1 | 1991 | 364 | 0.010 |
Why?
|
|
Jakate's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|